Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 777 - 784 of 11617 results
HHS Pushes Back on Accumulator Ruling, Prompting Wait-and-See Situation
December 21, 2023| News
Doing Well to Do Good
December 21, 2023| Article| Viewpoint
Chicago Employers Must Now Provide Sick Leave and PTO to Employees
December 21, 2023| Blog| Viewpoint
2023: Another Year Chock Full of Challenges for FDA
December 20, 2023| Blog| Viewpoint
Ontario Employment Matters: 2023 Round Up and What’s Ahead in 2024
December 19, 2023| News
Senators Consider Reforms to Antitrust Law to Address Algorithmic Price-Fixing and Self-Preferencing — AI: The Washington Report
December 19, 2023| Article| Viewpoint
Carveouts, Add-ons Key As PE Firms Strategize For 2024
December 19, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.